Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMVDCGZ)

Drug Name

Pyridoxamine Drug Info

Synonyms

Pyridorin (TN)

Indication

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

DME

Drug Status:

Clinical Trial Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Advanced glycosylation end product receptor (AGER)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
PF-4494700	DMJ7IKW	Alzheimer disease	8A20	Phase 3	[4]
Alagebrium chloride	DMD741P	Hypotension	BA20-BA21	Phase 2/3	[5]
TTP-448	DMR37X8	Alzheimer disease	8A20	Phase 2	[4]
TTP-4000	DMCG01R	Alzheimer disease	8A20	Phase 1	[6]
DBT-066	DMFYCQ1	Dementia	6D80-6D86	Investigative	[7]
------------------------------------------------------------------------------------

Drug(s) Metabolized By Pyridoxamine-phosphate oxidase (PNPO)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Pyridoxine-5'-Phosphate	DMFUNL1	Discovery agent	N.A.	Investigative	[8]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Advanced glycosylation end product receptor (AGER)	TTMO9HF	RAGE_HUMAN	Inhibitor	[2]

------------------------------------------------------------------------------------

Drug-Metabolizing Enzyme (DME)

DME Name	DME ID	UniProt ID	MOA	REF
Pyridoxamine-phosphate oxidase (PNPO)^{Main DME}	DE3Z1RA	PNPO_HUMAN	Substrate	[3]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT02156843) Pyridorin in Diabetic Nephropathy. U.S. National Institutes of Health.
2	Pyridoxamine, an inhibitor of advanced glycation end product (AGE) formation ameliorates insulin resistance in obese, type 2 diabetic mice. Protein Pept Lett. 2010 Sep;17(9):1177-81.
3	An LC-MS/MS-based method for the quantification of pyridox(am)ine 5'-phosphate oxidase activity in dried blood spots from patients with epilepsy. Anal Chem. 2017 Sep 5;89(17):8892-8900.
4	Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease. Expert Opin Investig Drugs. 2015 Mar;24(3):393-9.
5	Effect of the age cross-link breaker alagebrium on anterior segment physiology, morphology, and ocular age and rage. Trans Am Ophthalmol Soc. 2009 Dec;107:146-58.
6	Receptor for advanced glycation end products: its role in Alzheimer's disease and other neurological diseases. Future Neurol. 2009; 4(2): 167-177.
7	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2843).
8	Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-beta signalling pathway in epithelial ovarian cancer. Cell Death Dis. 2017 Dec 13;8(12):3214.